About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lactoferrin Treatment in HIV Patients

NCT01830595·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Jason Baker

With

Ventria Bioscience

Age

40–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. HIV-positive participants receiving Antiretroviral Therapy (ART) for \>1 year
2. HIV RNA level \<200 copies/mL for at least 6 months (≥2 separate values)
3. Age \>40 years

You may not be if

1. Prior cardiovascular disease or stroke
2. Diabetes
3. Rheumatologic Diseases
4. Pregnancy
5. Chronic kidney disease, stage IV or V (creatinine clearance \<30 mL/min/1.73m2)
6. Cirrhosis or end-stage liver disease

The record

StatusCompleted

PhasePhase 2

Taking part55

StartedSep 2014

UpdatedDec 31, 2024

Conditions

Where1

Hennepin County Medical Center
Minneapolis, Minnesota, United States

Clareo Health | Lactoferrin Treatment in HIV Patients